Global Immunological Agents Market Research Report 2023

Publisher Name :
Date: 20-Jan-2023
No. of pages: 110
Inquire Before Buying

Highlights

The global Immunological Agents market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Immunological Agents is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Immunological Agents is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Immunological Agents in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Immunological Agents include Abbott, Organon, Pfizer, Sandoz, Amneal Pharmaceuticals, Apotex, Teva Pharmaceuticals, Biocon and Bristol Myers Squibb, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Immunological Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunological Agents.

The Immunological Agents market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Immunological Agents market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immunological Agents companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Abbott

- Organon

- Pfizer

- Sandoz

- Amneal Pharmaceuticals

- Apotex

- Teva Pharmaceuticals

- Biocon

- Bristol Myers Squibb

- Merck

- CSL Behring

- Sanofi

- Leading Pharma

- Accord Healthcare Inc

- Amgen

- Nabi Biopharmaceuticals

- Ascend Laboratories

- Camber Pharmaceuticals Inc

- Grifols USA

- JOM Pharmaceuticals

Segment by Type

- Antirheumatic Drugs (DMARDs)

- Immune Globulins

- Immunomodulatory Agents

- Immunosuppressive Agents

- Monoclonal Antibodies

- Other

Segment by Application

- Hospital

- Clinics

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immunological Agents companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Immunological Agents Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunological Agents Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antirheumatic Drugs (DMARDs)
1.2.3 Immune Globulins
1.2.4 Immunomodulatory Agents
1.2.5 Immunosuppressive Agents
1.2.6 Monoclonal Antibodies
1.2.7 Other
1.3 Market by Application
1.3.1 Global Immunological Agents Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunological Agents Market Perspective (2018-2029)
2.2 Immunological Agents Growth Trends by Region
2.2.1 Global Immunological Agents Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immunological Agents Historic Market Size by Region (2018-2023)
2.2.3 Immunological Agents Forecasted Market Size by Region (2024-2029)
2.3 Immunological Agents Market Dynamics
2.3.1 Immunological Agents Industry Trends
2.3.2 Immunological Agents Market Drivers
2.3.3 Immunological Agents Market Challenges
2.3.4 Immunological Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunological Agents Players by Revenue
3.1.1 Global Top Immunological Agents Players by Revenue (2018-2023)
3.1.2 Global Immunological Agents Revenue Market Share by Players (2018-2023)
3.2 Global Immunological Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunological Agents Revenue
3.4 Global Immunological Agents Market Concentration Ratio
3.4.1 Global Immunological Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunological Agents Revenue in 2022
3.5 Immunological Agents Key Players Head office and Area Served
3.6 Key Players Immunological Agents Product Solution and Service
3.7 Date of Enter into Immunological Agents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunological Agents Breakdown Data by Type
4.1 Global Immunological Agents Historic Market Size by Type (2018-2023)
4.2 Global Immunological Agents Forecasted Market Size by Type (2024-2029)
5 Immunological Agents Breakdown Data by Application
5.1 Global Immunological Agents Historic Market Size by Application (2018-2023)
5.2 Global Immunological Agents Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Immunological Agents Market Size (2018-2029)
6.2 North America Immunological Agents Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Immunological Agents Market Size by Country (2018-2023)
6.4 North America Immunological Agents Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunological Agents Market Size (2018-2029)
7.2 Europe Immunological Agents Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Immunological Agents Market Size by Country (2018-2023)
7.4 Europe Immunological Agents Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunological Agents Market Size (2018-2029)
8.2 Asia-Pacific Immunological Agents Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Immunological Agents Market Size by Region (2018-2023)
8.4 Asia-Pacific Immunological Agents Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunological Agents Market Size (2018-2029)
9.2 Latin America Immunological Agents Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Immunological Agents Market Size by Country (2018-2023)
9.4 Latin America Immunological Agents Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunological Agents Market Size (2018-2029)
10.2 Middle East & Africa Immunological Agents Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Immunological Agents Market Size by Country (2018-2023)
10.4 Middle East & Africa Immunological Agents Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Immunological Agents Introduction
11.1.4 Abbott Revenue in Immunological Agents Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Organon
11.2.1 Organon Company Detail
11.2.2 Organon Business Overview
11.2.3 Organon Immunological Agents Introduction
11.2.4 Organon Revenue in Immunological Agents Business (2018-2023)
11.2.5 Organon Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Immunological Agents Introduction
11.3.4 Pfizer Revenue in Immunological Agents Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Sandoz
11.4.1 Sandoz Company Detail
11.4.2 Sandoz Business Overview
11.4.3 Sandoz Immunological Agents Introduction
11.4.4 Sandoz Revenue in Immunological Agents Business (2018-2023)
11.4.5 Sandoz Recent Development
11.5 Amneal Pharmaceuticals
11.5.1 Amneal Pharmaceuticals Company Detail
11.5.2 Amneal Pharmaceuticals Business Overview
11.5.3 Amneal Pharmaceuticals Immunological Agents Introduction
11.5.4 Amneal Pharmaceuticals Revenue in Immunological Agents Business (2018-2023)
11.5.5 Amneal Pharmaceuticals Recent Development
11.6 Apotex
11.6.1 Apotex Company Detail
11.6.2 Apotex Business Overview
11.6.3 Apotex Immunological Agents Introduction
11.6.4 Apotex Revenue in Immunological Agents Business (2018-2023)
11.6.5 Apotex Recent Development
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Detail
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Immunological Agents Introduction
11.7.4 Teva Pharmaceuticals Revenue in Immunological Agents Business (2018-2023)
11.7.5 Teva Pharmaceuticals Recent Development
11.8 Biocon
11.8.1 Biocon Company Detail
11.8.2 Biocon Business Overview
11.8.3 Biocon Immunological Agents Introduction
11.8.4 Biocon Revenue in Immunological Agents Business (2018-2023)
11.8.5 Biocon Recent Development
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Detail
11.9.2 Bristol Myers Squibb Business Overview
11.9.3 Bristol Myers Squibb Immunological Agents Introduction
11.9.4 Bristol Myers Squibb Revenue in Immunological Agents Business (2018-2023)
11.9.5 Bristol Myers Squibb Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Immunological Agents Introduction
11.10.4 Merck Revenue in Immunological Agents Business (2018-2023)
11.10.5 Merck Recent Development
11.11 CSL Behring
11.11.1 CSL Behring Company Detail
11.11.2 CSL Behring Business Overview
11.11.3 CSL Behring Immunological Agents Introduction
11.11.4 CSL Behring Revenue in Immunological Agents Business (2018-2023)
11.11.5 CSL Behring Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Immunological Agents Introduction
11.12.4 Sanofi Revenue in Immunological Agents Business (2018-2023)
11.12.5 Sanofi Recent Development
11.13 Leading Pharma
11.13.1 Leading Pharma Company Detail
11.13.2 Leading Pharma Business Overview
11.13.3 Leading Pharma Immunological Agents Introduction
11.13.4 Leading Pharma Revenue in Immunological Agents Business (2018-2023)
11.13.5 Leading Pharma Recent Development
11.14 Accord Healthcare Inc
11.14.1 Accord Healthcare Inc Company Detail
11.14.2 Accord Healthcare Inc Business Overview
11.14.3 Accord Healthcare Inc Immunological Agents Introduction
11.14.4 Accord Healthcare Inc Revenue in Immunological Agents Business (2018-2023)
11.14.5 Accord Healthcare Inc Recent Development
11.15 Amgen
11.15.1 Amgen Company Detail
11.15.2 Amgen Business Overview
11.15.3 Amgen Immunological Agents Introduction
11.15.4 Amgen Revenue in Immunological Agents Business (2018-2023)
11.15.5 Amgen Recent Development
11.16 Nabi Biopharmaceuticals
11.16.1 Nabi Biopharmaceuticals Company Detail
11.16.2 Nabi Biopharmaceuticals Business Overview
11.16.3 Nabi Biopharmaceuticals Immunological Agents Introduction
11.16.4 Nabi Biopharmaceuticals Revenue in Immunological Agents Business (2018-2023)
11.16.5 Nabi Biopharmaceuticals Recent Development
11.17 Ascend Laboratories
11.17.1 Ascend Laboratories Company Detail
11.17.2 Ascend Laboratories Business Overview
11.17.3 Ascend Laboratories Immunological Agents Introduction
11.17.4 Ascend Laboratories Revenue in Immunological Agents Business (2018-2023)
11.17.5 Ascend Laboratories Recent Development
11.18 Camber Pharmaceuticals Inc
11.18.1 Camber Pharmaceuticals Inc Company Detail
11.18.2 Camber Pharmaceuticals Inc Business Overview
11.18.3 Camber Pharmaceuticals Inc Immunological Agents Introduction
11.18.4 Camber Pharmaceuticals Inc Revenue in Immunological Agents Business (2018-2023)
11.18.5 Camber Pharmaceuticals Inc Recent Development
11.19 Grifols USA
11.19.1 Grifols USA Company Detail
11.19.2 Grifols USA Business Overview
11.19.3 Grifols USA Immunological Agents Introduction
11.19.4 Grifols USA Revenue in Immunological Agents Business (2018-2023)
11.19.5 Grifols USA Recent Development
11.20 JOM Pharmaceuticals
11.20.1 JOM Pharmaceuticals Company Detail
11.20.2 JOM Pharmaceuticals Business Overview
11.20.3 JOM Pharmaceuticals Immunological Agents Introduction
11.20.4 JOM Pharmaceuticals Revenue in Immunological Agents Business (2018-2023)
11.20.5 JOM Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Immunological Agents Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Antirheumatic Drugs (DMARDs)
Table 3. Key Players of Immune Globulins
Table 4. Key Players of Immunomodulatory Agents
Table 5. Key Players of Immunosuppressive Agents
Table 6. Key Players of Monoclonal Antibodies
Table 7. Key Players of Other
Table 8. Global Immunological Agents Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Immunological Agents Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Immunological Agents Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Immunological Agents Market Share by Region (2018-2023)
Table 12. Global Immunological Agents Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Immunological Agents Market Share by Region (2024-2029)
Table 14. Immunological Agents Market Trends
Table 15. Immunological Agents Market Drivers
Table 16. Immunological Agents Market Challenges
Table 17. Immunological Agents Market Restraints
Table 18. Global Immunological Agents Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Immunological Agents Market Share by Players (2018-2023)
Table 20. Global Top Immunological Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunological Agents as of 2022)
Table 21. Ranking of Global Top Immunological Agents Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Immunological Agents Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Immunological Agents Product Solution and Service
Table 25. Date of Enter into Immunological Agents Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Immunological Agents Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Immunological Agents Revenue Market Share by Type (2018-2023)
Table 29. Global Immunological Agents Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Immunological Agents Revenue Market Share by Type (2024-2029)
Table 31. Global Immunological Agents Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Immunological Agents Revenue Market Share by Application (2018-2023)
Table 33. Global Immunological Agents Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Immunological Agents Revenue Market Share by Application (2024-2029)
Table 35. North America Immunological Agents Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Immunological Agents Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Immunological Agents Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Immunological Agents Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Immunological Agents Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Immunological Agents Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Immunological Agents Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Immunological Agents Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Immunological Agents Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Immunological Agents Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Immunological Agents Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Immunological Agents Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Immunological Agents Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Immunological Agents Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Immunological Agents Market Size by Country (2024-2029) & (US$ Million)
Table 50. Abbott Company Detail
Table 51. Abbott Business Overview
Table 52. Abbott Immunological Agents Product
Table 53. Abbott Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 54. Abbott Recent Development
Table 55. Organon Company Detail
Table 56. Organon Business Overview
Table 57. Organon Immunological Agents Product
Table 58. Organon Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 59. Organon Recent Development
Table 60. Pfizer Company Detail
Table 61. Pfizer Business Overview
Table 62. Pfizer Immunological Agents Product
Table 63. Pfizer Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 64. Pfizer Recent Development
Table 65. Sandoz Company Detail
Table 66. Sandoz Business Overview
Table 67. Sandoz Immunological Agents Product
Table 68. Sandoz Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 69. Sandoz Recent Development
Table 70. Amneal Pharmaceuticals Company Detail
Table 71. Amneal Pharmaceuticals Business Overview
Table 72. Amneal Pharmaceuticals Immunological Agents Product
Table 73. Amneal Pharmaceuticals Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 74. Amneal Pharmaceuticals Recent Development
Table 75. Apotex Company Detail
Table 76. Apotex Business Overview
Table 77. Apotex Immunological Agents Product
Table 78. Apotex Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 79. Apotex Recent Development
Table 80. Teva Pharmaceuticals Company Detail
Table 81. Teva Pharmaceuticals Business Overview
Table 82. Teva Pharmaceuticals Immunological Agents Product
Table 83. Teva Pharmaceuticals Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 84. Teva Pharmaceuticals Recent Development
Table 85. Biocon Company Detail
Table 86. Biocon Business Overview
Table 87. Biocon Immunological Agents Product
Table 88. Biocon Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 89. Biocon Recent Development
Table 90. Bristol Myers Squibb Company Detail
Table 91. Bristol Myers Squibb Business Overview
Table 92. Bristol Myers Squibb Immunological Agents Product
Table 93. Bristol Myers Squibb Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 94. Bristol Myers Squibb Recent Development
Table 95. Merck Company Detail
Table 96. Merck Business Overview
Table 97. Merck Immunological Agents Product
Table 98. Merck Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 99. Merck Recent Development
Table 100. CSL Behring Company Detail
Table 101. CSL Behring Business Overview
Table 102. CSL Behring Immunological Agents Product
Table 103. CSL Behring Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 104. CSL Behring Recent Development
Table 105. Sanofi Company Detail
Table 106. Sanofi Business Overview
Table 107. Sanofi Immunological Agents Product
Table 108. Sanofi Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 109. Sanofi Recent Development
Table 110. Leading Pharma Company Detail
Table 111. Leading Pharma Business Overview
Table 112. Leading Pharma Immunological Agents Product
Table 113. Leading Pharma Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 114. Leading Pharma Recent Development
Table 115. Accord Healthcare Inc Company Detail
Table 116. Accord Healthcare Inc Business Overview
Table 117. Accord Healthcare Inc Immunological Agents Product
Table 118. Accord Healthcare Inc Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 119. Accord Healthcare Inc Recent Development
Table 120. Amgen Company Detail
Table 121. Amgen Business Overview
Table 122. Amgen Immunological Agents Product
Table 123. Amgen Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 124. Amgen Recent Development
Table 125. Nabi Biopharmaceuticals Company Detail
Table 126. Nabi Biopharmaceuticals Business Overview
Table 127. Nabi Biopharmaceuticals Immunological Agents Product
Table 128. Nabi Biopharmaceuticals Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 129. Nabi Biopharmaceuticals Recent Development
Table 130. Ascend Laboratories Company Detail
Table 131. Ascend Laboratories Business Overview
Table 132. Ascend Laboratories Immunological Agents Product
Table 133. Ascend Laboratories Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 134. Ascend Laboratories Recent Development
Table 135. Camber Pharmaceuticals Inc Company Detail
Table 136. Camber Pharmaceuticals Inc Business Overview
Table 137. Camber Pharmaceuticals Inc Immunological Agents Product
Table 138. Camber Pharmaceuticals Inc Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 139. Camber Pharmaceuticals Inc Recent Development
Table 140. Grifols USA Company Detail
Table 141. Grifols USA Business Overview
Table 142. Grifols USA Immunological Agents Product
Table 143. Grifols USA Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 144. Grifols USA Recent Development
Table 145. JOM Pharmaceuticals Company Detail
Table 146. JOM Pharmaceuticals Business Overview
Table 147. JOM Pharmaceuticals Immunological Agents Product
Table 148. JOM Pharmaceuticals Revenue in Immunological Agents Business (2018-2023) & (US$ Million)
Table 149. JOM Pharmaceuticals Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunological Agents Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Immunological Agents Market Share by Type: 2022 VS 2029
Figure 3. Antirheumatic Drugs (DMARDs) Features
Figure 4. Immune Globulins Features
Figure 5. Immunomodulatory Agents Features
Figure 6. Immunosuppressive Agents Features
Figure 7. Monoclonal Antibodies Features
Figure 8. Other Features
Figure 9. Global Immunological Agents Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Immunological Agents Market Share by Application: 2022 VS 2029
Figure 11. Hospital Case Studies
Figure 12. Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. Immunological Agents Report Years Considered
Figure 15. Global Immunological Agents Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Immunological Agents Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Immunological Agents Market Share by Region: 2022 VS 2029
Figure 18. Global Immunological Agents Market Share by Players in 2022
Figure 19. Global Top Immunological Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunological Agents as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Immunological Agents Revenue in 2022
Figure 21. North America Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Immunological Agents Market Share by Country (2018-2029)
Figure 23. United States Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Immunological Agents Market Share by Country (2018-2029)
Figure 27. Germany Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Immunological Agents Market Share by Region (2018-2029)
Figure 35. China Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Immunological Agents Market Share by Country (2018-2029)
Figure 43. Mexico Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Immunological Agents Market Share by Country (2018-2029)
Figure 47. Turkey Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Immunological Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 50. Organon Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 51. Pfizer Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 52. Sandoz Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 53. Amneal Pharmaceuticals Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 54. Apotex Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 55. Teva Pharmaceuticals Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 56. Biocon Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 57. Bristol Myers Squibb Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 58. Merck Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 59. CSL Behring Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 60. Sanofi Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 61. Leading Pharma Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 62. Accord Healthcare Inc Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 63. Amgen Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 64. Nabi Biopharmaceuticals Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 65. Ascend Laboratories Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 66. Camber Pharmaceuticals Inc Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 67. Grifols USA Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 68. JOM Pharmaceuticals Revenue Growth Rate in Immunological Agents Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
  • Global Animal Auto-Immune Disease Diagnostics Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 86
    Highlights The global Animal Auto-Immune Disease Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Animal Auto-Immune Disease Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecas......
  • Global Angiographic Catheters Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 95
    Highlights The global Angiographic Catheters market was valued at US$ 1282.9 million in 2022 and is anticipated to reach US$ 1869.7 million by 2029, witnessing a CAGR of 5.4% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Angiographic Catheters is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period o......
  • Global African Horse Sickness Treatment Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 60
    Highlights The global African Horse Sickness Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for African Horse Sickness Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of ......
  • Global Aflatoxicosis Treatment Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 85
    Highlights The global Aflatoxicosis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Aflatoxicosis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • Global Advanced Infusion Systems Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 85
    Highlights The global Advanced Infusion Systems market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Advanced Infusion Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2......
  • Global Addison Disease Testing Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 91
    Highlights The global Addison Disease Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Addison Disease Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • Global Children Emergency Cervical Collars Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 97
    Highlights The global Children Emergency Cervical Collars market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Children Emergency Cervical Collars is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast......
  • Global Adult Emergency Cervical Collars Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 91
    Highlights The global Adult Emergency Cervical Collars market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Adult Emergency Cervical Collars is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast perio......
  • Global Rigid Emergency Cervical Collars Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 91
    Highlights The global Rigid Emergency Cervical Collars market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Rigid Emergency Cervical Collars is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast perio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs